MODIFICATION
Q -- Phase I - Serological Assays for the detection and characterization of influenza viruses
- Notice Date
- 11/14/2024 1:27:19 PM
- Notice Type
- Solicitation
- NAICS
- 325413
— In-Vitro Diagnostic Substance Manufacturing
- Contracting Office
- CDC OFFICE OF ACQUISITION SERVICES ATLANTA GA 30333 USA
- ZIP Code
- 30333
- Solicitation Number
- 75D30125R73211_Phase_I
- Response Due
- 11/21/2024 11:00:00 AM
- Archive Date
- 04/28/2025
- Point of Contact
- Jennifer Gartzke, Phone: 4044980020
- E-Mail Address
-
jgartzke@cdc.gov
(jgartzke@cdc.gov)
- Small Business Set-Aside
- SBA Total Small Business Set-Aside (FAR 19.5)
- Description
- The objective of this contract is to support the Influenza Division through the testing of human sera via hemagglutination inhibition assay as well as develop a new serology platform that is comparable to hemagglutination inhibition assay.
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/9b7ce42c9dbe49d7b0d808b6f8712ffd/view)
- Place of Performance
- Address: Atlanta, GA, USA
- Country: USA
- Record
- SN07264537-F 20241116/241114230104 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |